| Focus on INNOVATION
The key to future success in our industry is innovation.
Diagnostics technologies are ever changing and improvin.
Despite the short product life cycles that characterize
this industry, IMMCO consistently adapts to the needs
of the market through its commitment to R&D. The
staples of future diagnostic medicine are being developed
today.
The vast majority of our current products and services
were derived directly from internal research. To speed
development, IMMCO has partnered with a number of prominent
researchers and distinguished institutions. These collaborations
are producing new technologies to extend the existing
menu of tests and establish new proprietary tests within
the field of autoimmunity as well as in significant
associated markets.
IMMCO R&D is supported by the following units:
- ASSAY DEVELOPMENT
- MOLECULAR BIOLOGY
- BIOPOLYMER
These units collaborate in the identification, expression, purification and development of new markers for patentable assays and detection systems.
Our R&D unit is also uniquely qualified to evaluate cellular and humoral autoimmune responses in various species. Contract services are available upon request. |
Site Location: Corporate
>> R & D 
